Utilization and cost effectiveness of standardized testing for screening and confirmation of drugs of abuse in urine

Annals of Clinical and Laboratory Science

Volumn 32, Issue 4, 2002, Pages 387-392

  Lum, Gifford ^a  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Assay standardization; Confirmation; Cost analysis; Drugs of abuse in urine; Utilization

Indexed keywords

ILLICIT DRUG;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG ABUSE; DRUG SCREENING; HEALTH CARE UTILIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOLDIER; STANDARDIZATION; URINALYSIS;

COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HOSPITALS, VETERANS; HUMANS; MALE; STREET DRUGS; SUBSTANCE ABUSE DETECTION; VETERANS;

EID: 0036756636     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Oellerich M. Enzyme immunoassays in clinical chemistry. Present status and trends. J Clin Chem Clin Biochem 1980;18:197-208.
2. Operation Manual. RemediHS Drug Profiling System. BioRad Laboratories, Hercules, CA, March, 1998.
3. Simpson D, Greenwood J, Jarvie DR, Moore FM. Experience of a laboratory service for drug screening in urine. Scott Med J 1993;38:20-26.
4. Schiller MJ, Shumway M, Batki SL. Patterns of substance use among patients in an urban psychiatric emergency service. Psych Services 2000;51:113-115.
5. Bailey DN. Results of limited versus comprehensive toxicology screening in a university medical center. Amer J Clin Path 1996;105:572-575.
6. Braithwaite RA, Jarvie DR, Minty PS, Simpson D, Widdop B. Screening for drugs of abuse. I: Opiates, amphetamines and cocaine. Ann Clin Biochem 1995;32:123-153.
7. Dasgupta A, Saldana S, Kinnaman G, Smith M, Johansen K. Analytical performance of EMIT II monoclonal amphetamine/methamphetamine assay: More specificity than EMIT DAU monoclonal amphetamine/methamphetamine assay. Clin Chem 1993;39:104-108.
8. Smith-Kielland A, Olsen KM, Christophersen AS. False-positive results with EMIT II amphetamine/ methamphetamine assay in users of common psychotropic drugs. Clin Chem 1995;41:951-952.
9. Urine Drug Testing in the Clinical Laboratory; Approved Guideline. National Committee for Clinical Laboratory Standards (document T/DM8-A, vol 19. no 6), Wayne, PA, 1999.
10. Schiller MJ, Shumway M, Batki SL. Utility of routine drug screening in a psychiatric emergency setting. Psych Services 2000;51:474-478.
11. Perrone J, DeRoos F, Jayaraman S, Hollander JE. Drug screening versus history in detection of substance abuse in ED psychiatric patients. Amer J Emerg Med 2001;19:49-51.
12. Saxon AJ, Calsyn DA, Haver VM, Erickson L. A nationwide survey of urinalysis practices of methadone maintenance clinics: Utilization of laboratory services. Arch Pathol Lab Med 1990;114: 94-100.